• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核壳结构上转换纳米晶-树枝状大分子复合物作为载体用于线粒体靶向和过氧化物酶增强的抗癌光动力治疗。

Core-shell structured upconversion nanocrystal-dendrimer composite as a carrier for mitochondria targeting and catalase enhanced anti-cancer photodynamic therapy.

机构信息

State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; University of Science and Technology of China, Hefei, 230026, China.

State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China; Key Laboratory of Superlight Materials and Surface Technology Ministry of Education, College of Material Sciences and Chemical Engineering, Harbin Engineering University, Harbin, 150001, China.

出版信息

Biomaterials. 2020 May;240:119850. doi: 10.1016/j.biomaterials.2020.119850. Epub 2020 Feb 11.

DOI:10.1016/j.biomaterials.2020.119850
PMID:32092593
Abstract

Recently, photodynamic therapy (PDT) has been deemed to be the most promising strategy for cancer treatment. To improve the efficacy for PDT, nanocarriers are expected to target mitochondria that are vulnerable to toxic reactive oxygen species (ROS). Moreover, overcoming tumor hypoxia is also conducive to enhance the PDT efficacy. Upconversion nanoparticles (UCNPs) can convert near infrared (NIR) light to visible light, thus stimulating photosensitizers to effectively produce cytotoxic ROS and achieving a high tissue penetration depth. In this study, a multifunctional nanocarrier UCNPs@G4/Ce6/CAT-CTPP was synthesized by a novel thiol-ene and azide-acetylene click reaction route to connect the original oleic acid ligands and dendrimers. Interestingly, the constructed "hydrophobic and hydrophilic pockets" around one single upconversion nanoparticle can simultaneously load hydrophobic photosensitizer Chlorin e6 (Ce6) and hydrophilic catalase (CTA) for catalytic enhanced PDT activated by NIR laser. Also, the mitochondrial targeting molecules (3-carboxypropyl) triphenylphosphonium bromide (CTPP) were modified outside of the dendrimers to efficiently target mitochondria. Both the catalytic degradation of hydrogen peroxide (HO) by catalase to overcome tumor hypoxia and mitochondrial targeting greatly enhance the efficacy of PDT. More importantly, this system provides a new paradigm for designing inorganic nanocrystal core and dendrimer shell for cargo delivery.

摘要

最近,光动力疗法(PDT)被认为是治疗癌症最有前途的策略。为了提高 PDT 的疗效,期望纳米载体能够靶向对毒性活性氧(ROS)敏感的线粒体。此外,克服肿瘤缺氧也有利于增强 PDT 的疗效。上转换纳米粒子(UCNPs)可以将近红外(NIR)光转换为可见光,从而刺激光敏剂有效地产生细胞毒性 ROS,并实现高组织穿透深度。在本研究中,通过一种新的硫醇-烯和叠氮-乙炔点击反应途径,合成了一种多功能纳米载体 UCNPs@G4/Ce6/CAT-CTPP,以连接原始的油酸配体和树枝状大分子。有趣的是,在单个上转换纳米粒子周围构建的“疏水性和亲水性口袋”可以同时负载疏水性光敏剂氯卟啉 e6(Ce6)和亲水性过氧化氢酶(CTA),用于 NIR 激光激活的催化增强 PDT。此外,修饰在树枝状大分子外部的线粒体靶向分子(3-羧丙基)三苯基膦溴化物(CTPP)可有效靶向线粒体。过氧化氢酶对过氧化氢(HO)的催化降解以克服肿瘤缺氧和线粒体靶向大大增强了 PDT 的疗效。更重要的是,该系统为设计用于货物输送的无机纳米晶核和树枝状大分子壳提供了一种新的范例。

相似文献

1
Core-shell structured upconversion nanocrystal-dendrimer composite as a carrier for mitochondria targeting and catalase enhanced anti-cancer photodynamic therapy.核壳结构上转换纳米晶-树枝状大分子复合物作为载体用于线粒体靶向和过氧化物酶增强的抗癌光动力治疗。
Biomaterials. 2020 May;240:119850. doi: 10.1016/j.biomaterials.2020.119850. Epub 2020 Feb 11.
2
Mitochondria-Targeting Upconversion Nanoparticles@MOF for Multiple-Enhanced Photodynamic Therapy in Hypoxic Tumor.基于 MOF 的线粒体靶向上转换纳米粒子用于缺氧肿瘤的多重增强光动力治疗。
ACS Appl Mater Interfaces. 2023 Aug 2;15(30):35884-35894. doi: 10.1021/acsami.3c05447. Epub 2023 Jul 24.
3
Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.基于产氧过氧化氢酶的前药纳米颗粒克服缺氧介导的化学-光动力疗法中的耐药性
Acta Biomater. 2020 Aug;112:234-249. doi: 10.1016/j.actbio.2020.05.035. Epub 2020 Jun 2.
4
Sequential-targeting nanocarriers with pH-controlled charge reversal for enhanced mitochondria-located photodynamic-immunotherapy of cancer.具有 pH 控制电荷反转的序贯靶向纳米载体增强癌症线粒体定位光动力免疫治疗。
Acta Biomater. 2020 Mar 15;105:223-238. doi: 10.1016/j.actbio.2020.01.005. Epub 2020 Jan 9.
5
Upconversion nanoparticle-based optogenetic nanosystem for photodynamic therapy and cascade gene therapy.用于光动力疗法和级联基因治疗的基于上转换纳米颗粒的光遗传学纳米系统。
Acta Biomater. 2023 Feb;157:538-550. doi: 10.1016/j.actbio.2022.12.002. Epub 2022 Dec 6.
6
Deep-penetrating photodynamic therapy with KillerRed mediated by upconversion nanoparticles.上转换纳米粒子介导的KillerRed深部穿透光动力疗法
Acta Biomater. 2017 Mar 15;51:461-470. doi: 10.1016/j.actbio.2017.01.004. Epub 2017 Jan 4.
7
UV-emitting upconversion-based TiO2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway.基于上转换发光的 TiO2 敏化纳米平台:通过线粒体参与的凋亡途径介导近红外光体内光动力治疗。
ACS Nano. 2015 Mar 24;9(3):2584-99. doi: 10.1021/nn506107c. Epub 2015 Feb 20.
8
Periodic mesoporous organosilica coupled with chlorin e6 and catalase for enhanced photodynamic therapy to treat triple-negative breast cancer.载氯原卟啉介孔有机硅与过氧化氢酶的周期性介孔有机硅用于增强光动力疗法治疗三阴性乳腺癌。
J Colloid Interface Sci. 2022 Mar 15;610:634-642. doi: 10.1016/j.jcis.2021.11.107. Epub 2021 Nov 22.
9
808 nm Light-triggered and hyaluronic acid-targeted dual-photosensitizers nanoplatform by fully utilizing Nd(3+)-sensitized upconversion emission with enhanced anti-tumor efficacy.808nm 光触发和透明质酸靶向双光敏剂纳米平台,充分利用 Nd(3+)-敏化上转换发射,增强抗肿瘤疗效。
Biomaterials. 2016 Sep;101:32-46. doi: 10.1016/j.biomaterials.2016.05.024. Epub 2016 May 21.
10
808 nm Near-Infrared Light-Excited UCNPs@mSiO-Ce6-GPC3 Nanocomposites For Photodynamic Therapy In Liver Cancer.808nm 近红外光激发的上转换纳米粒子@介孔硅-二氢卟吩 e6-肝癌特异性嵌合肽纳米复合材料用于光动力学治疗肝癌。
Int J Nanomedicine. 2019 Dec 20;14:10009-10021. doi: 10.2147/IJN.S221496. eCollection 2019.

引用本文的文献

1
From Structure to Function: The Promise of PAMAM Dendrimers in Biomedical Applications.从结构到功能:聚酰胺-胺型树枝状大分子在生物医学应用中的前景
Pharmaceutics. 2025 Jul 18;17(7):927. doi: 10.3390/pharmaceutics17070927.
2
Recent advances in phototherapy-based nanomedicine of lymphoma.基于光疗法的淋巴瘤纳米医学的最新进展。
Mater Today Bio. 2025 Jul 3;33:102047. doi: 10.1016/j.mtbio.2025.102047. eCollection 2025 Aug.
3
Illuminating Hope for Tumors: The Progress of Light-Activated Nanomaterials in Skin Cancer.照亮肿瘤的希望:光激活纳米材料在皮肤癌治疗中的进展
Int J Nanomedicine. 2025 Apr 18;20:5081-5118. doi: 10.2147/IJN.S506000. eCollection 2025.
4
Advances in targeted therapy for tumor with nanocarriers: A review.纳米载体用于肿瘤靶向治疗的研究进展:综述
Mater Today Bio. 2025 Feb 15;31:101583. doi: 10.1016/j.mtbio.2025.101583. eCollection 2025 Apr.
5
Organelle-Targeting Nanoparticles.细胞器靶向纳米颗粒
Adv Sci (Weinh). 2025 Feb;12(7):e2411720. doi: 10.1002/advs.202411720. Epub 2025 Jan 13.
6
Pioneering Advances and Innovative Applications of Mesoporous Carriers for Mitochondria-Targeted Therapeutics.介孔载体用于线粒体靶向治疗的开创性进展与创新应用
Br J Biomed Sci. 2024 Nov 18;81:13707. doi: 10.3389/bjbs.2024.13707. eCollection 2024.
7
Advancements in mitochondrial-targeted nanotherapeutics: overcoming biological obstacles and optimizing drug delivery.线粒体靶向纳米治疗学的进展:克服生物学障碍和优化药物传递。
Front Immunol. 2024 Oct 17;15:1451989. doi: 10.3389/fimmu.2024.1451989. eCollection 2024.
8
Differentiated management of ROS level in tumor and kidney to alleviate Cis-platinum induced acute kidney injury with improved efficacy.肿瘤和肾脏中 ROS 水平的差异化管理,以提高疗效缓解顺铂诱导的急性肾损伤。
J Nanobiotechnology. 2024 Jul 24;22(1):436. doi: 10.1186/s12951-024-02710-2.
9
Temoporfin-Conjugated PEGylated Poly(,-dimethylacrylamide)-Coated Upconversion Colloid for NIR-Induced Photodynamic Therapy of Pancreatic Cancer.卟啉-聚乙二醇化聚(甲基丙烯酰胺)-包覆上转换胶体用于近红外光诱导胰腺癌光动力治疗。
Biomacromolecules. 2024 Sep 9;25(9):5771-5785. doi: 10.1021/acs.biomac.4c00317. Epub 2024 Jun 18.
10
Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.细胞器靶向药物递送:关键挑战、最新进展和治疗意义。
Endocr Metab Immune Disord Drug Targets. 2024;24(13):1480-1487. doi: 10.2174/0118715303282573240112104035.